Jurors’ skepticism about the truth and accuracy of scientific evidence offered by the parties in litigation is a disturbing trend from 2025 that likely will continue to grow in 2026.
The second Trump administration appears to be changing the FDA approval landscape and new opportunities and pitfalls abound for defendants seeking to establish the all-powerful preemption defense.
In-house counsel at engineering and construction firms need to prepare for this fast-evolving landscape
Companies must develop a coherent, consistent, and comprehensive strategy at each stage of a recall, the public announcement, and subsequent litigation.
Why we expect a significant responsive uptick in state AG enforcement to fill the vacuum left by DOJ and other federal regulators.
Early applications of Loper Bright suggest that the rollback of Chevron deference could meaningfully reshape agency authority and corporate liability in environmental cases.
